Fundraising FoxGenoa Ventures — 2021 Investments
4 investments dated 2021 · listed companies and verified rows first · show all
Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.
AgTechBiotechDeep Tech
Ricardo Garcia de Albain
Co-investorsKurma PartnersSofinnova PartnersCasdin Capital
New Culture produces animal-free dairy cheese products, starting with mozzarella for pizzerias, using food science to replicate the taste, melt, and stretch of conventional cheese.
Climate TechFoodTechSan Leandro, US
Matthew Gibson(Executive Officer, Director)inInja Radman(Founder)inMatt Gibson(Founder)inMatt Gibson Inja Radman(Founder)
BoardSteve Sanger(Director)
Co-investorsAhren Innovation CapitalAsymmetry VenturesBee PartnersS2G InvestmentsSynthesis CapitalCPT Capital+1 more
SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.
AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US
Joe Peterson(Co-founder)John Cole(Co-founder)Tushar Pandey(Co-founder)inStacey Stevens(Executive Officer, Director)in
BoardVikram Chaudhery(Director)inLucy Coassin(Director)
Co-investorsAV8 VenturesKleinmuntz AssociatesXcellerant VenturesGENERAL INCEPTIONNorthpond Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.